John W. Cumming - 01 Jul 2021 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Role
Director
Signature
/s/ John Sprague, Attorney-in-Fact
Issuer symbol
TTOO
Transactions as of
01 Jul 2021
Net transactions value
-$21,091
Form type
4
Filing time
02 Jul 2021, 16:00:17 UTC
Previous filing
29 Jun 2021
Next filing
28 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTOO Common Stock Sale $21,091 -18,182 -26% $1.16 50,852 01 Jul 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 20, 2021, to cover payment of tax liability incident to the vesting of restricted stock units.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.16 to $1.19. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.